JPWO2020120548A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020120548A5
JPWO2020120548A5 JP2021534321A JP2021534321A JPWO2020120548A5 JP WO2020120548 A5 JPWO2020120548 A5 JP WO2020120548A5 JP 2021534321 A JP2021534321 A JP 2021534321A JP 2021534321 A JP2021534321 A JP 2021534321A JP WO2020120548 A5 JPWO2020120548 A5 JP WO2020120548A5
Authority
JP
Japan
Prior art keywords
ethinyl estradiol
amorphous
cyclodextrin
tetrahydrofolic acid
cyclodextrin complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021534321A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513237A (ja
JP7499252B2 (ja
Publication date
Priority claimed from EP18382921.7A external-priority patent/EP3666260A1/en
Application filed filed Critical
Publication of JP2022513237A publication Critical patent/JP2022513237A/ja
Publication of JPWO2020120548A5 publication Critical patent/JPWO2020120548A5/ja
Application granted granted Critical
Publication of JP7499252B2 publication Critical patent/JP7499252B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021534321A 2018-12-13 2019-12-11 エチニルエストラジオール-β-シクロデキストリン複合体およびその製造方法 Active JP7499252B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382921.7A EP3666260A1 (en) 2018-12-13 2018-12-13 Ethinyl estradiol-beta-cyclodextrin complex and process for preparing thereof
EP18382921.7 2018-12-13
PCT/EP2019/084591 WO2020120548A1 (en) 2018-12-13 2019-12-11 ETHINYL ESTRADIOL-β-CYCLODEXTRIN COMPLEX AND PROCESS FOR PREPARING THEREOF

Publications (3)

Publication Number Publication Date
JP2022513237A JP2022513237A (ja) 2022-02-07
JPWO2020120548A5 true JPWO2020120548A5 (enExample) 2022-12-19
JP7499252B2 JP7499252B2 (ja) 2024-06-13

Family

ID=65003157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021534321A Active JP7499252B2 (ja) 2018-12-13 2019-12-11 エチニルエストラジオール-β-シクロデキストリン複合体およびその製造方法

Country Status (5)

Country Link
US (1) US12318395B2 (enExample)
EP (1) EP3666260A1 (enExample)
JP (1) JP7499252B2 (enExample)
ES (1) ES2850278B2 (enExample)
WO (1) WO2020120548A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3666260A1 (en) 2018-12-13 2020-06-17 Laboratorios Leon Farma SA Ethinyl estradiol-beta-cyclodextrin complex and process for preparing thereof
CN114225050B (zh) * 2022-01-29 2022-12-13 国家卫生健康委科学技术研究所 炔雌醇环糊精复合物的制备及应用
CN116617157B (zh) * 2023-05-25 2025-02-18 国家卫生健康委科学技术研究所 一种制备pH响应性炔雌醇复合水凝胶的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
DE4426709A1 (de) 1994-07-20 1996-01-25 Schering Ag Steroidale Sexualhormone enthaltende feste Arzneiformen
IT1304190B1 (it) 1998-12-18 2001-03-08 Euphar Group Srl Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche
CH693905A5 (de) 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
EP2906603B1 (en) 2012-10-10 2017-08-16 The University of Queensland Encapsulation of gases within cyclodextrins
EP2781214A1 (en) 2013-03-22 2014-09-24 Chemo Research, S.L. Formulation of amorphous calcium L-5-methyltetrahydrofolate (L-5-MTHF-Ca)
WO2016097025A1 (en) 2014-12-19 2016-06-23 Synthon B.V. Pharmaceutical composition comprising amorphous lenalidomide
EP3666260A1 (en) 2018-12-13 2020-06-17 Laboratorios Leon Farma SA Ethinyl estradiol-beta-cyclodextrin complex and process for preparing thereof

Similar Documents

Publication Publication Date Title
AU2021203265B2 (en) Orodispersible dosage unit containing an estetrol component
EP2854763B1 (en) Formulations for vaginal delivery of antiprogestins
JP6813150B2 (ja) エステトロールを含有する口腔内崩壊錠
JP6866561B2 (ja) エステトロールを含有する口腔内崩壊錠
RU2009103649A (ru) Фармацевтическая композиция, содержащая тетрагидрофолиевую кислоту
JP2009542591A5 (enExample)
JP2004518656A5 (enExample)
JPH04290830A (ja) 避妊薬処方物
HU213408B (en) Process for producing pharmaceutical compositions comprising drospirenon
CA2432151A1 (en) Compositions of estrogen-cyclodextrin complexes
JP2000514785A (ja) プロゲストゲン―抗プロゲストゲン処方
JP2008540482A5 (enExample)
CA2608639A1 (en) Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl-(6s)-tetrahydrofolate
CN101208107A (zh) 四阶段连续累进的雌激素避孕药
US20200222315A1 (en) Formulations and methods for vaginal delivery of antiprogestins
JP7499252B2 (ja) エチニルエストラジオール-β-シクロデキストリン複合体およびその製造方法
JPWO2020120548A5 (enExample)
ES2438734T3 (es) Anticonceptivo que contiene ácido fólico
EP1948181B1 (de) Darreichungsform zur hormonalen kontrazeption
CN103877058A (zh) 一种左炔诺孕酮片及其制备工艺
JP2001523639A (ja) プロゲストゲン−抗プロゲストゲンレジメン